Bora Pharmaceuticals Co., Ltd.
6472
Rank in Stocks
#6838
Globally, Bora Pharmaceuticals Co., LTD. is engaged in the comprehensive... Globally, Bora Pharmaceuticals Co., LTD. is engaged in the comprehensive lifecycle of pharmaceutical products, encompassing research and development, manufacturing, distribution, and sales. The organization operates through key divisions, including Sales, Contract Development & Manufacturing Organization (CDMO), and other ancillary services. Bora produces and markets a diverse range of medicines, from generic and proprietary brand-name drugs to over-the-counter (OTC) remedies. Beyond its in-house portfolio, the company provides extensive contract development and manufacturing solutions. These CDMO services cover all stages of pharmaceutical development, clinical and commercial production, specialized packaging and serialization, rigorous analytical and microbiological quality control, and expert guidance on regulatory compliance. Furthermore, Bora's offerings extend to nutritional supplements, skincare products, and various biotechnical services. The company distributes its goods directly to healthcare facilities such as clinics, pharmacies, and pharmacy chains, as well as to drugstores. It also leverages distributors to supply larger institutions like medical centers, corporate and public hospitals, and regional and district hospitals. Established in 2007, Bora Pharmaceuticals Co., LTD. is based in Taipei City, Taiwan.
Share Price
$12.20
Last synced: 2026-11-13
Market Cap
$1.56B
Change (1 day)
0.05%
Change (1 year)
-34.32%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Bora Pharmaceuticals Co., Ltd. (6472)
Category
Healthcare
EPS for Bora Pharmaceuticals Co., Ltd. (6472)
EPS as of June 2026 TTM: $0.37
According to Bora Pharmaceuticals Co., Ltd.'s latest financial reports, its current EPS (TTM) is $0.37. At the end of 2025 the company had an EPS of $0.76, a decrease compared to its 2024 EPS of $0.98.
EPS history for Bora Pharmaceuticals Co., Ltd. from 2019 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $0.37 | -50.96% |
| 2025 | $0.76 | -22.23% |
| 2024 | $0.98 | 19.28% |
| 2023 | $0.82 | 111.63% |
| 2022 | $0.39 | 66.77% |
| 2021 | $0.23 | 29.73% |
| 2020 | $0.18 | 89.14% |
| 2019 | $0.09 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $6.03 | 1,517.90% |
DE
|
|
| $6.01 | 1,511.97% |
DE
|
|
| $1.53 | 311.30% |
JP
|
|
| $3.66 | 882.02% |
CH
|
|
| $0.45 | 20.74% |
IL
|
Questions about Bora Pharmaceuticals Co., Ltd.'s earnings per share (EPS)
What is Bora Pharmaceuticals Co., Ltd.'s earnings per share (EPS)?
Bora Pharmaceuticals Co., Ltd.'s earnings per share (EPS) over the last twelve months is $0.37, as of Jun 2026.
What was Bora Pharmaceuticals Co., Ltd.'s earnings per share (EPS) in 2025?
In 2025, Bora Pharmaceuticals Co., Ltd.'s earnings per share (EPS) was $0.76, 22.45% less than in 2024 ($0.98).
How has Bora Pharmaceuticals Co., Ltd.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, Bora Pharmaceuticals Co., Ltd.'s earnings per share (EPS) went from $0.18 to $0.76, an average growth of 33.39% a year.
How does Bora Pharmaceuticals Co., Ltd.'s earnings per share (EPS) compare with similar companies?
Bora Pharmaceuticals Co., Ltd.'s earnings per share (EPS) ($0.37) is lower than that of all 5 similar companies listed above. The highest among them is MERCK Kommanditgesellschaft auf Aktien, with $6.03.